Harte Hanks Inc (HHS)
Official siteINDUSTRIALS • CONGLOMERATES • NASDAQ
Market Cap: $28.70M
Last updated: Nov 17, 2026 at 4:10 PM ET
Harte Hanks Inc (HHS) Statistics
Harte Hanks (HHS) has a market cap of $28.70M and an enterprise value of $32.63M. It earned -$4.94M on revenue of $154.58M over the last 12 months.
Total Valuation
Enterprise value is 13.70% above the market cap, as debt exceeds cash.
| Market Cap | $28.70M |
|---|---|
| Enterprise Value | $32.63M |
| Latest price (Nov 17, 2026) | $3.76 |
Key Dates
The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 15, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.2x and 2.0x. Its year-end P/S ranged from 0.1x to 0.4x from 2016 to 2025.
| P/S Ratio | 0.2x |
|---|---|
| P/B Ratio | 2.0x |
| P/TBV Ratio | 2.1x |
Price Statistics
The stock is up 26.17% over 52 weeks and trades 11.53% below its 50-day average.
| Beta (1Y) | 0.49 |
|---|---|
| 52-Week Change | +26.17% |
| 1-Month Change | -13.76% |
| 3-Month Change | -0.53% |
| 6-Month Change | +44.62% |
| 5-Year Change | -46.62% |
| 10-Year Change | -72.55% |
| Total Return (1Y) | +26.17% |
| Total Return (3Y CAGR) | -18.94% |
| Total Return (5Y CAGR) | -15.44% |
| Return vs SPY (1Y) | +23.69% |
| Max Drawdown (1Y) | -46.95% |
| Max Drawdown (3Y) | -77.25% |
| Sharpe Ratio (1Y) | 0.44 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $4.25 |
| 200-Day Average | $3.13 |
| 52-Week Range | $2.00 to $4.67 |
| RSI (14 Days) | 34.9 |
| Average Volume (20 Days) | 52.41K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.23x current liabilities, and total debt is 0.45x shareholder equity.
| Current Ratio | 1.23x |
|---|---|
| Quick Ratio | 1.23x |
| Debt / Equity | 0.45x |
Returns and Efficiency
Return on invested capital is -25.01% over the last 12 months, against a 5-year average of -2.98%.
| Return on Equity (ROE) | -34.96% |
|---|---|
| Return on Assets (ROA) | -5.60% |
| Return on Invested Capital (ROIC) | -25.01% |
| Return on Capital Employed (ROCE) | -15.73% |
| ROA (5Y Average) | 2.52% |
| ROIC (5Y Average) | -2.98% |
| Asset Turnover | 1.71x |
| Receivables Turnover | 4.12x |
Scores
HHS has an Altman Z-Score of 14.62, in the safe zone above 2.99, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 14.62 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $154.58M over the last 12 months is down 7.35% from the 12 months before.
| Revenue | $154.58M |
|---|---|
| Revenue Growth (YoY) | -7.35% |
| Gross Profit | $73.35M |
| Operating Income | -$7.16M |
| Pretax Income | -$8.20M |
| Net Income | -$4.94M |
| EBITDA | -$3.60M |
| EBIT | -$7.86M |
| Reported EPS (TTM) | -$0.66 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 16.02% of the $88.15M in total assets.
| Cash and Equivalents | $2.37M |
|---|---|
| Total Debt | $6.30M |
| Net Debt | $3.93M |
| Net Debt Per Share | $0.53 |
| Working Capital | $8.85M |
| Shareholder Equity | $14.12M |
| Book Value Per Share | $1.89 |
| Tangible Book Value | $13.60M |
| Tangible Book Per Share | $1.83 |
| Total Assets | $88.15M |
| Total Liabilities | $74.03M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.86M of capital spending, operating cash flow left -$9.87M of free cash flow.
| Operating Cash Flow | -$8.01M |
|---|---|
| Capital Expenditures | $1.86M |
| Free Cash Flow | -$9.87M |
| FCF Per Share | -$1.32 |
| Depreciation and Amortization | $4.26M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -4.63%, against a 5-year average of 2.88%.
| Gross Margin | 47.45% |
|---|---|
| Operating Margin | -4.63% |
| Pretax Margin | -5.30% |
| Net Margin | -3.19% |
| EBITDA Margin | -2.33% |
| EBIT Margin | -5.09% |
| FCF Margin | -6.39% |
| Gross Margin (5Y Average) | 48.07% |
| Operating Margin (5Y Average) | 2.88% |
| Net Margin (5Y Average) | 1.57% |
Growth
Revenue fell 8.20% a year over 3 years.
| Revenue Growth (3Y CAGR) | -8.20% |
|---|---|
| Revenue Growth (5Y CAGR) | -2.04% |
| Operating Income Growth (3Y CAGR) | -70.55% |
| Book Value Per Share Growth (2Y CAGR) | +0.51% |
| Tangible Book Per Share Growth (2Y CAGR) | +13.33% |
Dividends and Yields
HHS does not pay a dividend. Its free cash flow yield is -35.22%.
| FCF Yield | -35.22% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-10 reverse split on Feb 1, 2018.
| Last Split Date | Feb 1, 2018 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Peer Position
Against 10 similar companies, HHS has the 9th highest P/S.
P/S RatioPeer median 0.6x
ROICPeer median -3.42%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.92%
| P/S Ratio | 0.2x vs 0.6x median |
|---|---|
| ROIC | -25.01% vs -3.42% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -7.35% vs +13.92% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HHS
What is HHS's market cap?
Harte Hanks has a market cap of $28.70M. Its enterprise value, which adds debt and subtracts cash, is $32.63M.
How many shares of HHS are outstanding?
Harte Hanks has 7.45M shares outstanding. The count is up 0.53% from a year earlier.
Does HHS pay a dividend?
No. Harte Hanks does not pay a dividend.
How much debt does HHS have?
Harte Hanks has $6.30M of total debt and $2.37M of cash and equivalents, a net debt position of $3.93M.
HHS pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors